Supplemental Table 1 from The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 1. Clinical characteristics of AML patients who provided specimens for this study.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361919962